70527 100 mM IPTG Solution - Novagen

View Pricing & Availability


Replacement Information

Key Spec Table

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
Retrieving availability...
Limited AvailabilityLimited Availability
In Stock 
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Glass bottle 15 ml
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
      Request Pricing
      OverviewThe lac operon inducer IPTG (isopropyl-β-D- 1-thiogalactopyranoside) is recommended for blue/white screening by lacZ α- complementation with appropriate vectors and host strains, such as pSTBlue-1/NovaBlue, and for inducing protein expression with the pET System and other lac promoter-derived expression systems. The preparation is dioxane-free and supplied as a sterile aqueous solution, in convenient volumes (10 × 1.5 ml).
      Catalogue Number70527
      Brand Family Novagen®
      SynonymsIPTG Solution, 100 mM
      Product Information
      CAS number367-93-1
      Quality LevelMQ100
      Biological Information
      Physicochemical Information
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped with Blue Ice or with Dry Ice
      Toxicity Carcinogenic / Teratogenic
      Storage -20°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Packaging Information
      Transport Information
      Supplemental Information


      100 mM IPTG Solution - Novagen SDS


      Safety Data Sheet (SDS) 

      100 mM IPTG Solution - Novagen Certificates of Analysis

      TitleLot Number


    • Torsten Kessler, et al. (2005) Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature. Clinical Cancer Research 11, 6317-6324.
    • Eugenia Mata-Greenwood, et al. (2005) Cyclic stretch increases VEGF expression in pulmonary arterial smooth muscle cells via TGF-{beta}1 and reactive oxygen species: a requirement for NAD(P)H oxidase. American Journal of Physiology: Lung 289, L288-L289.